In March, Ahmedabad-based Torrent Pharma become the first drug maker to debut its oral brands, Semalix and Sembolic, after the Delhi High Court in a patent suit filed against Torrent, ruled that its formulation falls outside the range protected by the innovator
Through improved solid-phase synthesis techniques and automated platforms, pharmaceutical companies achieve higher yields, faster production cycles, and enhanced quality control, with many manufacturers finding that these innovations ultimately deliver scalable production capabilities and competitive pricing advantages in diabetes treatment markets
"It's been amazing," Barkley said
We order what is useful, not a generic panel
This is an illicit global market that endangers patients, puts big money in the pockets of organised criminals, and undermines legitimate healthcare